These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 15548230

  • 1. Dopamine, depression and antidepressants.
    Dailly E, Chenu F, Renard CE, Bourin M.
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA, Dougherty D, Rosenbaum JF.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI.
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [Abstract] [Full Text] [Related]

  • 4. Dopaminergic deficit and mood disorders.
    Pania L, Gessab GL.
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S1-7; discussion S7. PubMed ID: 12685916
    [Abstract] [Full Text] [Related]

  • 5. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression.
    Benkert O, Gründer G, Wetzel H.
    Pharmacopsychiatry; 1992 Nov; 25(6):254-60. PubMed ID: 1362997
    [Abstract] [Full Text] [Related]

  • 6. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G, Friedman A.
    Prog Brain Res; 2008 Nov; 172():265-86. PubMed ID: 18772037
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A silver bullet for the treatment of depression?
    Duman RS.
    Neuron; 2007 Sep 06; 55(5):679-81. PubMed ID: 17785173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU, Marks DM, Han C, Patkar AA, Steffens D.
    Int J Neurosci; 2008 Nov 06; 118(11):1515-22. PubMed ID: 18853330
    [Abstract] [Full Text] [Related]

  • 12. New approaches to the treatment of depression.
    Leonard BE.
    J Clin Psychiatry; 1996 Nov 06; 57 Suppl 4():26-33. PubMed ID: 8636063
    [Abstract] [Full Text] [Related]

  • 13. Possible use of amantadine in depression.
    Huber TJ, Dietrich DE, Emrich HM.
    Pharmacopsychiatry; 1999 Mar 06; 32(2):47-55. PubMed ID: 10333162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ, Swiergiel AH, de Beaurepaire R.
    Neurosci Biobehav Rev; 2005 Mar 06; 29(4-5):891-909. PubMed ID: 15885777
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ.
    J Clin Psychiatry; 2008 Mar 06; 69 Suppl E1():4-7. PubMed ID: 18494537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.